|PURE Bioscience, Inc.|
1725 Gillespie Way
United States - Map
Pure Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States. It manufactures and distributes silver dihydrogen citrate based disinfecting and sanitizing products. The companys technology platform is based on an electrochemical process that allows generating ionized silver in the presence of organic acid. It provides PURE Hard Surface, a hard surface disinfectant and food contact surface sanitizer for use in food processing equipment, machinery, and utensils; PURE Multi-Purpose Cleaner, an environmentally cleaning product for use in various resilient surfaces, such as floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate, an environmentally high foam forming cleaning product for use in stainless steel equipment, resilient floors, walls, and painted surfaces. The company also offers Axen 30, a hard surface disinfectant; Axenohl, an antimicrobial formulation used as a raw material in the manufacturing of environmental protection agency-registered products; and Silvérion, an antimicrobial formulation used as a raw material in the manufacturing of personal care products. Pure Bioscience, Inc. markets and sells its products primarily to distributors and end users. The company was formerly known as Pure Bioscience and changed its name to Pure Bioscience, Inc. in March 2011. Pure Bioscience, Inc. was founded in 1992 and is based in El Cajon, California.
|Mr. Henry R. Lambert ,
Chief Exec. Officer and Director
|Mr. Peter C. Wulff ,
Chief Financial Officer, Chief Operating Officer and Corp. Sec.
|Mr. Tom Myers ,
Exec. VP of Marketing and Product Devel.
|Mr. Cliff Wechsler ,
Exec. VP of Sales
|Mr. Don Markley ,
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|